Visual Analysis of Shexiang Baoxin Pills for Treating Coronary Heart Disease Based on CiteSpace

CHEN Zhihao; ZHANG Ning; LIU Luyao; JIAO Xueyan; ZHANG Yifan; CHEN Yun; LAN Zhenzhen; LIU Xincan

doi:10.12102/j.issn.1672-1349.2024.01.004

Abstract：Objective:Based on CiteSpace tool,the literature of Shexiang Baoxin Pill for the treatment of coronary heart disease was visually analyzed,and the research hotspot and development trend in this field were explored.Methods:China National Knowledge Infrastructure(CNKI),WanFang Data,and Chinese Science and Technology Journal Database(VIP)were used to search the published Chinese literature of the treatment of coronary heart disease with Shexiang Baoxin Pills.The search period was from January 1,2013 to January 1,2023.CiteSpace 6.2.R4 software was used to draw and analyze the knowledge map of authors,institutions,and keywords.Results:A total of 940 articles and 263 authors were included.There were four research teams represented by Yang Guoliang,Xue Zengming,Wang Huanchao,and Wu Haixia.Among the 255 institutions included,the top 3 institutions with the number of documents were the Department of Pharmacy of the Third Hospital of Hebei Medical University,the Hospital of Traditional Chinese Medicine of Qinghe County in Hebei Province,and the Department of Cardiology of the Affiliated Hospital of Changchun University of Traditional Chinese Medicine.There were 9 keywords clusters,the hotspots were mainly focused for the treatment,efficacy and safety of different traditional Chinese medicine syndrome types,and main evaluation indicators.Ten new key words were obtained,cardiac function,metoprolol,hypertension,and inflammatory factors were the research hotspots in this field in recent five years.Conclusion:The research for the treatment of coronary heart disease with Shexiang Baoxin Pills is in a period of rapid development,but there is no extensive contact between researchers and institutions,so it is necessary to strengthen communication and cooperation.